Synapse - Department of Medicine

Results (96)

Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: A Children’s Oncology Group study

Journal Article

Karajannis, M. A.; Onar-Thomas, A.; Lin, T.; Baxter, P. A.; Boué, D. R.; Cole, B. L.; Fuller, C.; Haque, S.; Jabado, N.; Lucas, J. T. Jr; more...
Neuro-Oncology (2025)

Fulltext@MSK | Save

Long-term efficacy and safety of larotrectinib in patients with TRK fusion primary central nervous system (CNS) tumors: An updated analysis

Meeting Abstract

Perreault, S.; Spano, J. P.; Nilsson, A.; Deyell, R. J.; Doz, F.; Geoerger, B.; Gumus, M.; Lassen, U. N.; Nysom, K.; Valero-Arrese, L.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Central nervous system bridging radiotherapy (CNS-BRT) achieves rapid cytoreduction prior to car T-cell therapy for aggressive B-cell lymphomas

Meeting Abstract

Cederquist, G.; Schefflein, J.; Devlin, S.; Shah, G.; Shouval, R.; Hubbeling, H.; Tringale, K.; Fregonese, B.; Hajj, C.; Boardman, A.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Patterns of intracranial response and relapse after CNS-directed radiotherapy (CNS-RT) for patients with chemorefractory or progressive secondary CNS lymphoma (SCNSL)

Meeting Abstract

Cederquist, G.; Tringale, K.; Hajj, C.; Moore, Z.; Hubbeling, H.; Dreyfuss, A.; Fregonese, B.; Falchi, L.; Scordo, M.; Grommes, C.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Prospective germline sequencing of patients with gliomas, glioneuronal or neuronal tumors

Meeting Abstract

Lin, A.; Nandakumar, S.; Mehine, M.; Kemel, Y.; Mandelker, D.; Karajannis, M.; Sait, S. F.; Gavrilovic, I.; Pentsova, E.; Schaff, L.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Utility of circulating tumor DNA (ctDNA) from cerebrospinal fluid (CSF) for prognosis of patients with recurrent high-grade glioma

Meeting Abstract

Miller, A. M.; Nandakumar, S.; Holle, B. M.; Kreitzer, C.; Song, T.; Tartaro, M.; Hertz, C. A. J.; Rafailov, J.; Campos, C.; Brannon, A. R.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Real-world experience with circulating tumor DNA in cerebrospinal fluid in patients with central nervous system tumors

Meeting Abstract

Hickman, R.; Miller, A. M.; Holle, B. M.; Jee, J.; Liu, S. Y.; Ross, D.; Yu, H.; Riely, G. J.; Ombres, C.; Gerwitz, A.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Utility of circulating tumor DNA (CTDNA) from cerebrospinal fluid (CSF) for prognosis of patients with recurrent high-grade glioma

Meeting Abstract

Holle, B. M.; Nandakumar, S.; Kreitzer, C.; Song, T.; Tartaro, M.; Hertz, C. A. J.; Rafailov, J.; Campos, C.; Reiner, A. S.; Young, R.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Outcomes and relapse patterns in primary central nervous system lymphoma: Longitudinal analysis of 559 patients diagnosed from 1983 to 2020

Journal Article

Tringale, K. R.; Scordo, M.; Yahalom, J.; White, C.; Zhang, Z.; Vachha, B.; Cederquist, G.; Schaff, L.; Deangelis, L.; Grommes, C.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Safety and efficacy of BRAF inhibitor plixorafenib (FORE8394; PLX8394) in children and adults with recurrent, BRAF-altered primary central nervous system tumors (PCNST)

Meeting Abstract

de la Fuente, M.; Butowski, N. A.; Taylor, J.; Yaeger, R.; Tsai, F. Y. C.; Janku, F.; Allen, C. E.; Ammakkanavar, N.; Michelson, G.; Jiang, P.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save